Press Release | NeoGenomics Laboratories

July 2, 2018

NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018

June 25, 2018

NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock

June 1, 2018

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

May 25, 2018

NeoGenomics to Participate In Two Upcoming Investor Conferences

May 1, 2018

NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018

April 2, 2018

NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018

March 20, 2018

NeoGenomics Announces Executive Appointments

February 21, 2018

NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients